Gynaecological HPV related diseases where patients have been referred to colposcopy. Urological and Genital Diseases Gynaecological HPV related diseases
Conditions
Interventions
Participants in this trial are treated according to current treatment guidelines and followed at the colposcopy clinic accordingly. At enrolment participants fill in a detailed questionnaire on their
Sponsors
University of Helsinki and Helsinki University Hospital
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Any woman 18 years of age or older 2. Referred to colposcopy at Helsinki University Hospital
Exclusion criteria
Exclusion criteria: Under the age of 18
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of preterm birth after colposcopy and/or cervical treatment is measured using the information in hospital records and national health registries at five, seven and ten years after enrollment. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Prevalence, clearance, and incidence of new HPV infections is measured with the extra cervical brush samples (HPV genotyping) obtained at any visit at the colposcopy clinic up to two years after enrolment 2. Sensitivity and specificity of colposcopic evaluation is measured using data from hospital records up to two years after enrolment 3. Rate of complications of colposcopy and treatment and risk factors are measured using using data from hospital records up to two years after enrolment | — |
Countries
Finland
Contacts
Public ContactPekka Nieminen
Outcome results
None listed